Researchers Use Tear Samples of Scleroderma Patients To Gain New Insights Into How SSc Affects Eyes

Author: Christine Traxler
Date Published: September-2015
Source: Scleroderma News

A study was recently conducted to determine levels of vascular endothelial growth factor in the tears of patients with scleroderma. Vascular endothelial growth factor or VEGF has been found to play a major role in the development of new blood vessels in a number of diseases, including macular degeneration of the eye, diabetic retinopathy, retinopathy of prematurity and sickle cell retinopathy. In scleroderma, VEGF is believed to contribute to some of the eye complications related to the disease, including dry eye syndrome (DES), conjunctival telangiectasia, and filamentous keratitis.